China Evergrande New Energy Vehicle Group Limited (EVGRF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $2.17M is the value of all shares combined. Beta 1.12: the stock has moved about 12% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerChina Evergrande New Energy Vehicle Group Limited (EVGRF) trades at $0.0002. China Evergrande New Energy Vehicle Group Limited is an investment holding company focused on health management and new energy vehicles. Market cap: $2.17M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for EVGRF: EVGRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EVGRF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 27 months old (Jun 1, 2024), so the figures and score below describe that period, not today.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
EVGRF: 1/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
China Evergrande New Energy Vehicle Group Limited (EVGRF) Healthcare & Pipeline Overview
China Evergrande New Energy Vehicle Group Limited stands at the intersection of healthcare and sustainable transportation, offering a diverse portfolio that includes health management services and new energy vehicles, positioning itself as a multifaceted player in both sectors.
What Is the Investment Thesis for EVGRF?
China Evergrande New Energy Vehicle Group Limited presents a unique investment thesis driven by its dual focus on healthcare services and new energy vehicle production. The company's market cap of $2.17M and a P/E ratio of -0.14 indicate current challenges, yet its strategic initiatives in health management and new energy vehicles could unlock significant growth potential. The ongoing global shift towards sustainable practices and healthcare innovation presents a favorable backdrop for the company's expansion. Key value drivers include its diversified service offerings, potential for market share growth in the health management sector, and the increasing demand for new energy vehicles. The company's commitment to research and development in pharmaceuticals and medical technology further enhances its competitive positioning. However, investors should remain cautious of the negative profit margin of -890.5% and the gross margin of -3.8%, which highlight underlying operational challenges that need to be addressed for sustainable growth.
Based on FMP financials and quantitative analysis
EVGRF Key Highlights
Market cap of $2.17M reflects the company's current valuation amidst operational challenges.
- P/E ratio of -0.14 indicates negative earnings, suggesting potential financial instability.
- Profit margin of -890.5% highlights significant operational losses that need addressing.
- Gross margin of -3.8% indicates challenges in maintaining profitability in its business segments.
- Beta of 1.12 suggests higher volatility compared to the market, reflecting investor sentiment.
Who Are EVGRF's Competitors?
EVGRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AONC American Oncology Network, Inc. | $9.99 | 0.00% | $292M | — |
| BHCCF Benchmark Holdings plc | $0.37 | 0.00% | $225M | — |
| MAYNF Mayne Pharma Group Limited | $2.35 | 0.00% | $191M | — |
| MFCSF Medical Facilities Corporation | $10.95 | -1.35% | $192M | — |
| MKLNF M1 Kliniken AG | $11.73 | 0.00% | $215M | — |
| CCM Concord Medical Services Holdings Limited | $3.95 | -4.13% | — | |
| AMS American Shared Hospital Services | $1.42 | -4.70% | $9.41M | 465-pillar |
| SYRA Syra Health Corp. Class A Common Stock | $0.90 | +1.12% | $12.5M | 459-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are EVGRF's Key Strengths?
Diverse portfolio combining healthcare and new energy vehicle sectors.
- Established presence in the Chinese healthcare market.
- Strong potential for growth in the new energy vehicle segment.
- Commitment to research and development fostering innovation.
What Are EVGRF's Weaknesses?
Negative profit margin indicating operational challenges.
- High volatility reflected in beta of 1.12.
- Limited brand recognition outside of China.
- Dependence on the domestic market for most revenue.
What Could Drive EVGRF Stock Higher?
Expansion of healthcare services to meet rising demand in urban areas.
- Development of new energy vehicles aligning with global sustainability trends.
- Introduction of innovative healthcare technology solutions to enhance service delivery.
- Strategic partnerships with healthcare organizations to broaden market reach.
- Launch of new medical products and services in response to consumer needs.
What Are the Key Risks for EVGRF?
Financial-distress signal — its Altman Z-Score of -21.41 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory changes impacting healthcare and automotive operations.
- Financial instability reflected in negative profit margins.
- Competition from established players in both healthcare and new energy sectors.
- Economic downturns affecting consumer spending on healthcare services.
What Are the Growth Opportunities for EVGRF?
- Growth opportunity 1: The global health management market is expected to reach $1 trillion by 2027, driven by increasing consumer awareness and demand for personalized healthcare services. China Evergrande's focus on community health management and elderly care positions it to capture a significant share of this expanding market, particularly in urban areas where healthcare access is critical.
- Growth opportunity 2: The new energy vehicle market is projected to grow at a CAGR of 22% through 2027, driven by technological advancements and regulatory support for sustainable transportation. China Evergrande's investments in smart mobility solutions and lithium-ion battery production place it in a favorable position to benefit from this growth, particularly as global demand for electric vehicles continues to rise.
- Growth opportunity 3: The increasing prevalence of chronic diseases in China presents a substantial opportunity for the company's healthcare services. By expanding its offerings in medical cosmetology and anti-aging services, China Evergrande can tap into the growing consumer demand for preventative health measures and wellness solutions, potentially increasing its revenue streams.
- Growth opportunity 4: With the rise of telemedicine and digital health solutions, China Evergrande's software services can play a crucial role in enhancing healthcare delivery. By integrating technology into its health management services, the company can improve patient engagement and outcomes, positioning itself as a leader in innovative healthcare solutions.
- Growth opportunity 5: The company's commitment to research and development in pharmaceuticals and medical equipment production presents opportunities for innovation and market differentiation. By developing proprietary technologies and products, China Evergrande can enhance its competitive advantage and drive revenue growth in both the healthcare and new energy sectors.
What Threats Does EVGRF Face?
- Intense competition from established healthcare and automotive companies.
- Regulatory challenges in the healthcare and automotive sectors.
- Economic fluctuations impacting consumer spending on healthcare.
- Technological advancements by competitors could outpace company innovations.
What Are EVGRF's Competitive Advantages?
- Diversified service offerings that cater to both healthcare and sustainable transportation.
- Established brand reputation in the health management sector.
- Strategic investments in research and development for innovative solutions.
- Strong presence in the rapidly growing new energy vehicle market.
- Ability to leverage economies of scale in production and distribution.
What Does EVGRF Do?
Founded in 1999, China Evergrande New Energy Vehicle Group Limited, originally known as Evergrande Health Industry Group Limited, has evolved into a prominent investment holding company headquartered in Guangzhou, China. The company operates primarily in the healthcare sector, focusing on health management services and the development of new energy vehicles. With a commitment to enhancing community health, it provides a range of services, including community health management, medical cosmetology, anti-aging services, elderly care, and rehabilitation. In addition to healthcare services, China Evergrande New Energy Vehicle Group is involved in the wholesale of home care and healthcare products, alongside software services that support healthcare delivery. The company also engages in pharmaceutical research and development, medical equipment production, and the manufacture and sale of smart mobility solutions and lithium-ion batteries. Its strategic pivot to new energy vehicles reflects a growing emphasis on sustainability and innovation in transportation, aligning with global trends towards eco-friendly solutions. This diversification not only broadens its market reach but also positions the company favorably within the rapidly evolving landscape of health management and new energy sectors.
What Products and Services Does EVGRF Offer?
- Develops and sells health and living properties.
- Provides community health management services.
- Offers medical cosmetology and anti-aging services.
- Delivers elderly care and rehabilitation services.
- Wholesale of home care and healthcare products.
- Engages in pharmaceutical research and development.
- Produces medical equipment and smart mobility solutions.
- Manufactures and sells lithium-ion batteries.
How Does EVGRF Make Money?
- Revenue generated through health management services and community health programs.
- Sales from new energy vehicles and related products.
- Wholesale distribution of healthcare products and medical equipment.
- Software services that support healthcare delivery and management.
- Research and development initiatives that lead to innovative healthcare solutions.
What Industry Does EVGRF Operate In?
The healthcare sector, particularly in medical care facilities, is experiencing significant growth driven by an aging population and increasing demand for health management services. The global market for healthcare services is projected to expand as consumers seek comprehensive care solutions. Concurrently, the new energy vehicle market is witnessing rapid advancements, with a projected CAGR of 22% through 2027, driven by technological innovations and government incentives for sustainable transportation. China Evergrande New Energy Vehicle Group Limited is strategically positioned within this competitive landscape, leveraging its dual focus on health management and new energy vehicles to capitalize on emerging market trends.
Who Are EVGRF's Key Customers?
- Individuals seeking health management and wellness services.
- Elderly patients requiring rehabilitation and care.
- Healthcare facilities needing medical equipment and products.
- Consumers interested in new energy vehicles and smart mobility solutions.
- Government and private organizations looking for community health management partnerships.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 803 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 60 |
| 2026-08-26 | 60 |
| 2026-08-29 | 60 |
| 2026-09-01 | 60 |
| 2026-09-04 | 60 |
| 2026-09-07 | 60 |
| 2026-09-10 | 60 |
What changed?
The score has stayed at 60.
Over the same 18 days the stock moved +0.0%.
Company Profile
China Evergrande New Energy Vehicle Group Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Guangzhou, CN. The company is led by CEO Shawn Siu. EVGRF has traded publicly since 2021.
How China Evergrande New Energy Vehicle Group Limited Is Valued
China Evergrande New Energy Vehicle Group Limited carries a market capitalization of $2.17M, placing it in the micro-cap category.
Key Financial Metrics
Return on equity for China Evergrande New Energy Vehicle Group Limited stands at 20.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -34.2%, showing how much profit it generates from its asset base. Its free cash flow yield is -90.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.34 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
China Evergrande New Energy Vehicle Group Limited's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -21.41 places it in the distress zone, a signal of elevated financial risk.
EVGRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Diverse portfolio combining healthcare and new energy vehicle sectors.
- Established presence in the Chinese healthcare market.
- Strong potential for growth in the new energy vehicle segment.
- Commitment to research and development fostering innovation.
Bear Case
- Negative profit margin indicating operational challenges.
- High volatility reflected in beta of 1.12.
- Limited brand recognition outside of China.
- Dependence on the domestic market for most revenue.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2024 | CN¥5M | -CN¥40.83B | -CN¥3.77 |
Q2 FY2024 · filed 30 Jun 2024 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Reported in CNY
EVGRF Latest News
-
China's Evergrande Shares Halted As Hong Kong Court Orders Liquidation Of World's Most Indebted Developer With Over $300B In Liabilities
benzinga · Jan 29, 2024
-
Hong Kong Stocks End The Week In A Rout As China's Central Bank Pumps $100 Billion Into Banking System Ahead Of Long Weekend
benzinga · Oct 20, 2023
-
China's Largest Property Developer Misses Its First Bond Payment, While Another Heads To Court With Creditors Next Week
benzinga · Oct 18, 2023
-
Hong Kong Stocks Rally As Sovereign Bank Buy-Up Overshadows Climb In Negative Mortgages
benzinga · Oct 12, 2023
EVGRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EVGRF.
Price Targets
Wall Street price target analysis for EVGRF.
EVGRF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EVGRF; grades run from A+ (80-100) to F (below 30).
Latest News
China's Evergrande Shares Halted As Hong Kong Court Orders Liquidation Of World's Most Indebted Developer With Over $300B In Liabilities
Hong Kong Stocks End The Week In A Rout As China's Central Bank Pumps $100 Billion Into Banking System Ahead Of Long Weekend
China's Largest Property Developer Misses Its First Bond Payment, While Another Heads To Court With Creditors Next Week
Hong Kong Stocks Rally As Sovereign Bank Buy-Up Overshadows Climb In Negative Mortgages
Leadership: Shawn Siu
CEO
Shawn Siu has been instrumental in guiding China Evergrande New Energy Vehicle Group Limited through its strategic transformation. With a strong background in business management and operations, he has overseen the company's expansion into new markets and sectors. Siu holds a degree in Business Administration and has extensive experience in the healthcare and automotive industries, which positions him well to lead the company in its dual focus on health management and new energy vehicles.
Track Record: Under Shawn Siu's leadership, the company has diversified its offerings and strengthened its market position. His strategic decisions have led to increased investments in research and development, positioning China Evergrande to capitalize on emerging trends in both healthcare and sustainable transportation.
EVGRF OTC Market Information
The OTC Other tier includes companies that do not meet the listing requirements of major exchanges like NYSE or NASDAQ. These stocks may have lower liquidity and higher volatility, making them riskier investments. Companies in this tier often provide less financial transparency, which can be a concern for investors.
- OTC Tier: OTC Other
- Limited financial disclosures may result in a lack of transparency.
- Higher volatility and lower liquidity compared to stocks on major exchanges.
- Potential for significant price fluctuations based on market sentiment.
- Regulatory scrutiny may impact operations and stock performance.
- Verify the company's financial health through available reports.
- Assess the management team's experience and track record.
- Evaluate the competitive landscape and market positioning.
- Understand the regulatory environment affecting the business.
- Monitor industry trends that may impact growth prospects.
- Established history since 1999 in the healthcare sector.
- Diverse product offerings across healthcare and automotive sectors.
- Affiliation with China Evergrande Group enhances credibility.
- Engagement in research and development indicates commitment to innovation.
EVGRF Healthcare Stock FAQ
Is EVGRF a good stock?
Stock Expert AI does not rate EVGRF buy, sell or hold. China Evergrande New Energy Vehicle Group Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about EVGRF stock?
Analysts have mixed views on EVGRF stock, primarily due to its negative earnings and operational challenges. Key valuation metrics indicate financial instability, with a P/E ratio of -0.14 and a profit margin of -890.5%.
What are the key factors to evaluate for EVGRF?
Evaluate EVGRF on fundamentals, analyst consensus, and risk factors. China Evergrande New Energy Vehicle Group Limited presents a unique investment thesis driven by its dual focus on healthcare services and new energy vehicle production. Not financial advice.
How frequently does EVGRF data refresh on this page?
EVGRF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven EVGRF's recent stock price performance?
China Evergrande New Energy Vehicle Group Limited (EVGRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio combining healthcare and new energy vehicle sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EVGRF overvalued or undervalued right now?
China Evergrande New Energy Vehicle Group Limited (EVGRF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of EVGRF?
Yes, most major brokerages offer fractional shares of China Evergrande New Energy Vehicle Group Limited (EVGRF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EVGRF's earnings and financial reports?
China Evergrande New Energy Vehicle Group Limited (EVGRF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for EVGRF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information; operational challenges may impact future performance.